32.54
price down icon4.15%   -1.41
 
loading
Schlusskurs vom Vortag:
$33.95
Offen:
$33.26
24-Stunden-Volumen:
1.76M
Relative Volume:
0.76
Marktkapitalisierung:
$4.20B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-507.65M
KGV:
-7.0739
EPS:
-4.6
Netto-Cashflow:
$-616.24M
1W Leistung:
+2.17%
1M Leistung:
-1.87%
6M Leistung:
-63.25%
1J Leistung:
-53.02%
1-Tages-Spanne:
Value
$32.36
$33.80
1-Wochen-Bereich:
Value
$31.23
$36.84
52-Wochen-Spanne:
Value
$27.66
$121.06

Vaxcyte Inc Stock (PCVX) Company Profile

Name
Firmenname
Vaxcyte Inc
Name
Telefon
650-837-0111
Name
Adresse
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Name
Mitarbeiter
414
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-04
Name
Neueste SEC-Einreichungen
Name
PCVX's Discussions on Twitter

Vergleichen Sie PCVX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
PCVX
Vaxcyte Inc
32.54 4.11B 0 -507.65M -616.24M -4.60
Biotechnology icon
ONC
Beigene Ltd Adr
241.43 27.03B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
436.00 112.64B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.335 40.86M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
588.34 64.17B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
75.06 6.07B 0 -153.72M -103.81M -2.00

Vaxcyte Inc Stock (PCVX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-22 Eingeleitet Cantor Fitzgerald Overweight
2024-12-20 Eingeleitet Goldman Buy
2023-12-07 Eingeleitet Mizuho Buy
2023-04-18 Eingeleitet TD Cowen Outperform
2023-01-03 Bestätigt Needham Buy
2022-12-15 Eingeleitet Guggenheim Buy
2022-11-17 Eingeleitet BTIG Research Buy
2021-12-29 Fortgesetzt Jefferies Buy
2021-06-24 Fortgesetzt Jefferies Buy
2020-07-07 Eingeleitet BofA Securities Buy
2020-07-07 Eingeleitet Cantor Fitzgerald Overweight
2020-07-07 Eingeleitet Needham Buy
Alle ansehen

Vaxcyte Inc Aktie (PCVX) Neueste Nachrichten

pulisher
May 24, 2025

How the (PCVX) price action is used to our Advantage - news.stocktradersdaily.com

May 24, 2025
pulisher
May 20, 2025

James T. Wassil ’99G ’05G of Vaxcyte Inc., Tells Graduates ‘The Journey Ahead is Yours to Shape’ - Lehigh University

May 20, 2025
pulisher
May 13, 2025

Transcript : Vaxcyte, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 08 - marketscreener.com

May 13, 2025
pulisher
May 11, 2025

Vaxcyte, Inc. (NASDAQ:PCVX) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

May 11, 2025
pulisher
May 09, 2025

Is Vaxcyte, Inc. (PCVX) The Best Stock That Will Bounce Back? - MSN

May 09, 2025
pulisher
May 09, 2025

Vaxcyte, Inc. Reports Q1 2025 Financial Results - TipRanks

May 09, 2025
pulisher
May 08, 2025

11 Stocks That Will Bounce Back According to Analysts - Insider Monkey

May 08, 2025
pulisher
May 08, 2025

Decoding Vaxcyte Inc (PCVX): A Strategic SWOT Insight - GuruFocus

May 08, 2025
pulisher
May 07, 2025

Vaxcyte (PCVX) Advances Pneumococcal Vaccine Development | PCVX Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Vaxcyte Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 07, 2025
pulisher
May 07, 2025

Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

May 07, 2025
pulisher
May 07, 2025

Vaxcyte Inc Reports Q1 2025 EPS of -$1.04, Beating Estimates; Net Loss Widens to $140.7 Million - GuruFocus

May 07, 2025
pulisher
May 06, 2025

Oversold Conditions For Vaxcyte (PCVX) - Nasdaq

May 06, 2025
pulisher
May 03, 2025

Vaxcyte (PCVX) Stock Price, News & Analysis - MarketBeat

May 03, 2025
pulisher
May 01, 2025

Vaxcyte appoints new independent director - Investing.com Australia

May 01, 2025
pulisher
May 01, 2025

Vaxcyte appoints new independent director By Investing.com - Investing.com South Africa

May 01, 2025
pulisher
May 01, 2025

Vaxcyte (PCVX) Welcomes Former Sanofi CEO to Board of Directors | PCVX Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Vaxcyte (PCVX) Welcomes Former Sanofi CEO to Board of Directors - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Vaxcyte Appoints Dr. Olivier Brandicourt to Board - TipRanks

May 01, 2025
pulisher
May 01, 2025

Vaxcyte adds former Sanofi CEO to its board - Investing.com

May 01, 2025
pulisher
May 01, 2025

Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors | PCVX Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors - The Manila Times

May 01, 2025
pulisher
Apr 29, 2025

Is Vaxcyte, Inc. (PCVX) the Best Oversold NASDAQ Stock to Buy Right Now? - Yahoo Finance

Apr 29, 2025
pulisher
Apr 26, 2025

US Stocks Dip As Investors Eye Trump's Tariff Announcements - Finimize

Apr 26, 2025
pulisher
Apr 24, 2025

PCVXVaxcyte, Inc. Latest Stock News & Market Updates - Stock Titan

Apr 24, 2025
pulisher
Apr 24, 2025

James T. Wassil ’99G ’05G of Vaxcyte, Inc. Named Lehigh’s 2025 Graduate Commencement and Doctoral Hooding Ceremony Speaker - Lehigh University

Apr 24, 2025
pulisher
Apr 22, 2025

Vaxcyte (PCVX) Gains Attention with Overweight Rating Amid Marke - GuruFocus

Apr 22, 2025
pulisher
Apr 21, 2025

Vaxcyte (PCVX) Sees Surge in Investor Interest Amid Biotech Buzz - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Vaxcyte (PCVX) Sees Surge in Investor Interest Amid Biotech Buzz | PCVX Stock News - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Commit To Buy Vaxcyte At $20, Earn 14.7% Annualized Using Options - Nasdaq

Apr 21, 2025
pulisher
Apr 21, 2025

TD Cowen Keeps Their Buy Rating on Vaxcyte (PCVX) - The Globe and Mail

Apr 21, 2025
pulisher
Apr 18, 2025

When the Price of (PCVX) Talks, People Listen - news.stocktradersdaily.com

Apr 18, 2025
pulisher
Apr 17, 2025

2 ‘Strong Buy’ Growth Stocks That Could Gain More Than 340% - The Globe and Mail

Apr 17, 2025
pulisher
Apr 16, 2025

Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Apr 16, 2025
pulisher
Apr 12, 2025

Vaxcyte Stock Plummets 56% in a Month: Here's the Reason - MSN

Apr 12, 2025
pulisher
Apr 11, 2025

Vaxcyte Stock Plummets: What’s Next? - timothysykes.com

Apr 11, 2025
pulisher
Apr 11, 2025

Vaxcyte, Inc. (PCVX): Billionaire Stanley Druckenmiller’s Top Stock Pick with Huge Upside Potential - Insider Monkey

Apr 11, 2025
pulisher
Apr 09, 2025

Vaxcyte stock plunges to 52-week low at $29.53 amid market challenges - Investing.com India

Apr 09, 2025
pulisher
Apr 08, 2025

Vaxcyte stock plunges to 52-week low at $29.53 amid market challenges By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 05, 2025

Vaxcyte (NASDAQ:PCVX) Price Target Lowered to $137.00 at Bank of America - MarketBeat

Apr 05, 2025
pulisher
Apr 02, 2025

InvestingPro Fair Value model correctly predicted Vaxcyte’s decline By Investing.com - Investing.com UK

Apr 02, 2025
pulisher
Apr 02, 2025

Vaxcyte (NASDAQ:PCVX) Given New $137.00 Price Target at Bank of America - Defense World

Apr 02, 2025

Finanzdaten der Vaxcyte Inc-Aktie (PCVX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$1.15
price down icon 17.27%
$31.32
price down icon 3.63%
$587.61
price up icon 1.06%
$289.96
price up icon 0.33%
$4.25
price up icon 0.48%
$75.06
price up icon 3.26%
Kapitalisierung:     |  Volumen (24h):